Low Incidence of Paradoxical Bronchoconstriction with Bronchodilator Drugs Administered by Respimat® Soft Mist™ Inhaler: Results of Phase II Single-Dose Crossover Studies

D. Koehler,Demetri Pavia,Helen Dewberry,Rick Hodder

Low Incidence of Paradoxical Bronchoconstriction with Bronchodilator Drugs Administered by Respimat® Soft Mist™ Inhaler: Results of Phase II Single-Dose Crossover Studies

2004

D. Koehler
Demetri Pavia
Helen Dewberry
Rick Hodder

Background and Objectives: Respimat® Soft Mist™ Inhaler (SMI) is an innovative device that offers improved lung deposition and is an environmentally friendly alternative

Keywords:

Metered-dose inhaler
Anesthesia
Pathology
Inhaler
Asthma
Bronchodilator
Bronchoconstriction
COPD
Medicine
Respimat
lung deposition
soft mist inhaler

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations